DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Celgene (NASDAQ: CELG)



company name or ticker

Celgene Poised For Growth, 41% Upside

Is Merck Ready To Soar Or Flop? The Challenging Question Of Predicting Pipeline Potential

New Biotech ETFs Highlight Evolving Growth Opportunities

3 Stocks Benefiting From Jaw-Dropping Growth in Specialty Drug Spending

Spending on specialty drugs soared 31% last year, boosting sales at Gilead Sciences, Celgene Corporation, and AbbVie Inc.

3 Biotech Stocks Wall Street Loves

Wall Street analysts love these biotech stocks. Should you?

Should Gilead Sciences Inc.’s Slowing Growth Concern Investors?

Gilead Sciences has been one of the fastest-growing biotech companies over the past few years. The company's rocket-like growth trajectory, though, is expected to start slowing starting this year. Should investors be concerned?

The Average American Spends This Much On Healthcare Every Year -- Do You?

The typical American is spending more on healthcare.

Short Sellers Still Attracted To Biotech Stocks

The 4 Biggest Biotech Stocks In The Market

How Alan Leong of BioWatch NewsKeeps Successful Biotech Investing Simple

See More Articles...